hex

Board of Directors

Jeff K

Jeffrey B. Kindler

Chief Executive Officer, Centrexion Therapeutics

Jeffrey Kindler joined Centrexion Therapeutics as the chief executive officer in 2013. He has more than three decades of business experience and has held leadership positions at some of the world’s most recognized companies. Mr. Kindler serves on the board of directors of PPD, Perrigo Company PLC, Precigen, Inc. and Terns Pharmaceutical. He previously served on the board of directors of SIGA Technologies Inc. and vTv Therapeutics Inc. Mr. Kindler also serves as chair of the GLG Institute, a membership-based learning community for leading executives, and as a director or advisor to several private health care firms. Mr. Kindler is also a senior advisor to Blackstone and an operating partner at Artis Ventures.

Prior to joining Centrexion, Mr. Kindler was the chairman and chief executive officer of Pfizer Inc. As CEO, he led Pfizer’s $68 billion merger and acquisition of Wyeth, diversified its product portfolio, improved its research and development pipeline, and reshaped the company’s commercial, innovation and leadership models to drive growth and cultural change.

Earlier in his career, Mr. Kindler served as the executive vice president and general counsel for McDonald’s Corp., he was the vice president of litigation and legal policy for the General Electric Co. and he practiced civil and criminal litigation as a partner of William & Connolly.

Mr. Kindler holds a B.A. from Tufts University and a J.D. from Harvard University.